所有主题 精华主题 综合话题 体系认证 其它国家产品 中国产品 CE产品 美洲产品 版块公告 医疗器械认证 版主: 2iso | |||||
---|---|---|---|---|---|
状态 | 文章 | 作者 | 回复 | 人气 | 最后发表 |
[体系认证]
FDA |
Carey820412
2009-07-20 |
10 | 1124 | 2009-10-01 00:33 by: ce-iso13485 |
|
[体系认证]
含药器械 |
sgrkyo
2009-09-25 |
0 | 678 | 2009-09-25 13:30 by: sgrkyo |
|
[体系认证]
SFDA Regultions and Standards |
sgrkyo
2009-09-13 |
1 | 807 | 2009-09-21 21:31 by: sgrkyo |
|
[体系认证]
9706学习资料。95版和07版区别 |
scylqx
2009-05-05 |
6 | 926 | 2009-09-21 10:04 by: wmaixj |
|
[体系认证]
SFDA Comply Standards( +20 ) |
sgrkyo
2009-09-04 |
0 | 679 | 2009-09-04 08:46 by: sgrkyo |
|
[体系认证]
风险分析报告模板( +3 ) |
yyj_1976
2008-11-15 |
6 | 1883 | 2009-08-26 14:26 by: maoxiaoh |
|
[体系认证]
给几个查看认证的网址( +4 ) |
sgrkyo
2009-07-02 |
3 | 858 | 2009-08-12 12:03 by: yapi |
|
[体系认证]
救护车的电压波动范围 |
alpha
2009-08-01 |
6 | 885 | 2009-08-07 19:16 by: alpha |
|
[体系认证]
IEC60101第2版、第3版条款对照( +20 ) |
sgrkyo
2009-08-05 |
1 | 932 | 2009-08-05 21:53 by: 316979109 |
|
[体系认证]
工艺用气验证报告( +20 ) |
yyj_1976
2008-11-15 |
6 | 2631 | 2009-07-20 20:27 by: zhangwei1984 |
|
[体系认证]
医疗器械内审员培训(教材)( +20 ) |
xqppeng
2009-06-01 |
3 | 950 | 2009-07-02 14:36 by: david_pu1978 |
|
[体系认证]
不确定度( +15 ) |
sgrkyo
2009-07-01 |
1 | 690 | 2009-07-01 14:29 by: cgsh882 |
|
[体系认证]
医疗器械注册管理办法(16号令)( +20 ) |
sgrkyo
2009-06-29 |
0 | 1073 | 2009-06-29 20:27 by: sgrkyo |
|
[体系认证]
请教:ISO9001标准已换版,ISO13485是否也会进行修订? |
qqiw123456
2009-06-23 |
1 | 743 | 2009-06-23 20:23 by: 2iso |
|
[体系认证]
EN1060相关以及安全测试基本知识( +42 ) |
princelxx
2009-04-15 |
4 | 1139 | 2009-05-14 11:56 by: isofeng |
|
[体系认证]
发一些标准,GB4793...... |
scylqx
2009-05-05 |
7 | 956 | 2009-05-06 08:21 by: gengjunmei |
|
[体系认证]
ISO 12207 |
maindyn
2009-04-17 |
4 | 887 | 2009-04-20 15:59 by: bxj1123 |
|
[体系认证]
【求助】通知公告机构程序? |
坏坏小文文
2009-04-13 |
4 | 738 | 2009-04-14 15:03 by: 坏坏小文文 |
|
[体系认证]
ISO13485检查表(2003版含CE)( +15 ) |
坏坏小文文
2009-04-10 |
4 | 848 | 2009-04-13 20:23 by: yangzhenling |
|
[体系认证]
最新医学影像诊断系统等产品分类界定的通知( +8 ) |
vip658
2009-03-24 |
2 | 725 | 2009-03-25 13:02 by: vip658 |
|
在线用户:共0人在线,0位会员(0位隐身) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||